Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.

Jerrell JM, McIntyre RS, Park YM.

J Clin Psychiatry. 2014 Nov;75(11):e1278-83. doi: 10.4088/JCP.14m09046.

PMID:
25470092
[PubMed - indexed for MEDLINE]
3.

Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.

Norum J, Olsen AI, Nohr FI, Heyd A, Totth A.

Glob J Health Sci. 2014 Apr 14;6(4):155-62. doi: 10.5539/gjhs.v6n4p155.

PMID:
24999151
[PubMed - indexed for MEDLINE]
Free Article
4.

Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.

Eiland LS, Bell EA, Erramouspe J.

Ann Pharmacother. 2014 Oct;48(10):1350-5. doi: 10.1177/1060028014541791. Epub 2014 Jun 30. Review.

PMID:
24982313
[PubMed - indexed for MEDLINE]
5.

Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study.

Chen Q, Sjölander A, Runeson B, D'Onofrio BM, Lichtenstein P, Larsson H.

BMJ. 2014 Jun 18;348:g3769. doi: 10.1136/bmj.g3769.

PMID:
24942388
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Safety of medicines used for ADHD in children: a review of published prospective clinical trials.

Clavenna A, Bonati M.

Arch Dis Child. 2014 Sep;99(9):866-72. doi: 10.1136/archdischild-2013-304170. Epub 2014 Apr 19. Review.

PMID:
24748641
[PubMed - indexed for MEDLINE]
7.

Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.

Husarova V, Bittsansky M, Ondrejka I, Dobrota D.

Psychiatry Res. 2014 Apr 30;222(1-2):75-83. doi: 10.1016/j.pscychresns.2014.03.003. Epub 2014 Mar 15.

PMID:
24679996
[PubMed - indexed for MEDLINE]
8.

Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature.

Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, Smith BH.

Clin Psychol Rev. 2014 Apr;34(3):218-32. doi: 10.1016/j.cpr.2014.02.001. Epub 2014 Feb 27. Review.

PMID:
24632046
[PubMed - indexed for MEDLINE]
9.

[Drug therapy for AD/HD investigation of usefulness of extended-release methylphenidate and atomoxetine from the viewpoint of persistency rate].

Sugama M, Ishizaki A.

No To Hattatsu. 2014 Jan;46(1):22-5. Japanese.

PMID:
24620426
[PubMed - indexed for MEDLINE]
10.

Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.

Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY.

Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13.

PMID:
24432046
[PubMed]
Free PMC Article
11.

What place for lisdexamfetamine in children and adolescents with ADHD?

[No authors listed]

Drug Ther Bull. 2013 Oct;51(10):114-7. doi: 10.1136/dtb.2013.10.0208.

PMID:
24113146
[PubMed - indexed for MEDLINE]
12.

Toward systems neuroscience of shared and distinct neural effects of medications used to treat attention-deficit/hyperactivity disorder.

Castellanos FX, Meyer E.

Biol Psychiatry. 2013 Oct 15;74(8):560-2. doi: 10.1016/j.biopsych.2013.08.021. No abstract available.

PMID:
24075492
[PubMed - indexed for MEDLINE]
13.

Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.

Germinario EA, Arcieri R, Bonati M, Zuddas A, Masi G, Vella S, Chiarotti F, Panei P; Italian ADHD Regional Reference Centers.

J Child Adolesc Psychopharmacol. 2013 Sep;23(7):440-7. doi: 10.1089/cap.2012.0086. Epub 2013 Sep 11.

PMID:
24024538
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.

Setyawan J, Guérin A, Hodgkins P, Gauthier G, Cloutier M, Wu E, Erder MH.

J Med Econ. 2013 Nov;16(11):1275-89. doi: 10.3111/13696998.2013.839947. Epub 2013 Sep 19.

PMID:
24004347
[PubMed - indexed for MEDLINE]
16.

Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder.

Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, Montoya A, Quail D, Escobar R.

J Clin Psychopharmacol. 2013 Dec;33(6):766-74. doi: 10.1097/JCP.0b013e31829c762b.

PMID:
23963057
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.

Dittmann RW, Cardo E, Nagy P, Anderson CS, Bloomfield R, Caballero B, Higgins N, Hodgkins P, Lyne A, Civil R, Coghill D.

CNS Drugs. 2013 Dec;27(12):1081-92.

PMID:
23959815
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Autism and attention deficit hyperactivity disorder: pharmacological intervention].

Fernández-Jaén A, Martín Fernández-Mayoralas D, Fernández-Perrone AL, Calleja-Pérez B, Muñoz-Jareño N, López-Arribas S.

Rev Neurol. 2013 Sep 6;57 Suppl 1:S205-10. Review. Spanish.

PMID:
23897149
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.

Isaksson J, Hogmark Å, Nilsson KW, Lindblad F.

Psychiatry Res. 2013 Oct 30;209(3):740-1. doi: 10.1016/j.psychres.2013.06.011. Epub 2013 Jul 11.

PMID:
23850434
[PubMed - indexed for MEDLINE]
20.

Current Australian pediatric practice in the assessment and treatment of ADHD.

Efron D, Davies S, Sciberras E.

Acad Pediatr. 2013 Jul-Aug;13(4):328-33. doi: 10.1016/j.acap.2013.03.009.

PMID:
23830018
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk